Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

S. Rao, D. Cunningham, R. E. Hawkins, M. E. Hill, D. Smith, F. Daniel, P. J. Ross, J. Oates, A. R. Norman

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Neuroscience

    Agricultural and Biological Sciences

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology